Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $303.2M | $381.3M | $420.0M | $648.7M | $817.7M | $829.5M | $763.7M | $743.2M |
| Cost of revenue | $132.1M | $169.9M | $182.8M | $268.8M | $305.3M | $346.2M | $296.0M | $291.7M |
| Gross profit | $171.1M | $211.4M | $237.1M | $379.8M | $512.4M | $483.3M | $467.7M | $451.5M |
| Gross margin | 56.4% | 55.4% | 56.5% | 58.6% | 62.7% | 58.3% | 61.2% | 60.7% |
| R&D | $32.6M | $29.8M | $24.3M | $27.9M | $24.3M | $25.4M | $26.2M | $37.8M |
| Operating income | $17.5M | $42.8M | $74.7M | $181.4M | $255.8M | $220.3M | $179.5M | $173.1M |
| EBITDA | $27.0M | $55.4M | $89.6M | $196.6M | $271.3M | $238.0M | $199.6M | $216.4M |
| Net income | $17.9M | $39.3M | $61.1M | $153.1M | $199.7M | $170.3M | $136.9M | $140.4M |
| Net margin | 5.9% | 10.3% | 14.5% | 23.6% | 24.4% | 20.5% | 17.9% | 18.9% |
| EPS (diluted) | 0.35 | 0.71 | 1.10 | 2.76 | 3.73 | 3.20 | 2.67 | 2.75 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $764M | $2.51 | $2.43–$2.60 | 1 |
| 2027 | $888M | $3.43 | $3.32–$3.55 | 1 |
| 2028 | $971M | $4.19 | $4.06–$4.33 | 1 |
| 2029 | $1.1B | $4.63 | $4.48–$4.79 | 1 |
Forward consensus · source: Financial Modeling Prep
LABORATORIOS FARMACEUTICO
No one on the platform currently holds LABFF.
No tracked institution reports a position in LABFF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-14 | $0.9594 | 2026-07-15 |
| 2025-07-15 | $0.9351 | 2025-07-16 |
| 2024-07-09 | $1.1037 | 2024-07-10 |
| 2023-07-03 | $1.2938 | 2023-07-05 |
No one on the platform has traded LABFF yet.
| +0.00% |
| $2.6B |
| — |
| GNNSFGenscript Biotech Corporation | $1.60 | +0.00% | $3.5B | — |
| INCPFInnoCare Pharma Limited | $1.55 | +0.00% | $2.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.